Kinerase Available In The U.S. For Skin Treatment
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Kinerase Available In The U.S. For Skin Treatment

NEW YORK, NY -- March 8, 1999 -- ICN Pharmaceuticals, Inc.’s Kinerase(R) (N(6)-furfuryladenine), a skin cream to help inhibit signs of aging, is now available to the U.S. ethical skincare market, including dermatologists, plastic surgeons, and pharmacies.

Kinerase is a nature-identical plant growth factor, which helps partially reverse the effects of photoaging without irritating skin, according to studies conducted at a leading dermatology research centre in Southern California. When added to a cream or lotion in 0.1% concentration and applied to photodamaged skin, Kinerase helps improve tactile skin roughness, telangiectasias and mottled hyperpigmentation, with a very low incidence of any adverse effects.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities